MeiraGTx Holdings plc
General ticker "MGTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $599.6M (TTM average)
MeiraGTx Holdings plc follows the US Stock Market performance with the rate: 53.1%.
Estimated limits based on current volatility of 4.4%: low 9.31$, high 10.18$
Factors to consider:
- Total employees count: 381 (-10.4%) as of 2024
- Top business risk factors: High R&D costs, Regulatory and compliance, Market volatility, Supply chain disruptions, Cybersecurity threats
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.20$, 12.80$]
- 2026-12-31 to 2027-12-31 estimated range: [6.06$, 12.60$]
Financial Metrics affecting the MGTX estimates:
- Negative: with PPE of -5.6 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 1.89 <= 3.31
- Positive: -4.41 < Investing cash flow per share per price, % of -0.64
- Positive: Shareholder equity ratio, % of -2.37 <= 19.24
Short-term MGTX quotes
Long-term MGTX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $14.02MM | $33.28MM | $81.39MM |
| Operating Expenses | $151.08MM | $197.49MM | $187.36MM |
| Operating Income | $-137.06MM | $-164.21MM | $-105.97MM |
| Non-Operating Income | $53.03MM | $16.42MM | $-8.23MM |
| Interest Expense | $13.24MM | $13.27MM | $12.20MM |
| R&D Expense | $103.78MM | $119.48MM | $129.62MM |
| Income(Loss) | $-84.03MM | $-147.79MM | $-114.20MM |
| Net Income(Loss)* | $-84.03MM | $-147.79MM | $-114.20MM |
| Stockholders Equity | $138.18MM | $67.83MM | $-5.79MM |
| Inventory | $0.00MM | $0.39MM | $0.00MM |
| Assets | $326.74MM | $269.75MM | $244.43MM |
| Operating Cash Flow | $-105.36MM | $-104.50MM | $-46.36MM |
| Capital expenditure | $20.17MM | $4.96MM | $3.83MM |
| Investing Cash Flow | $34.03MM | $23.48MM | $-4.11MM |
| Financing Cash Flow | $84.02MM | $54.53MM | $12.27MM |
| Earnings Per Share** | $-1.49 | $-2.12 | $-1.42 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.